Showing results (2391-2400 of 3,012) with videos related to
Sort By:
Pageof 302
Plos One|February 21, 2012
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenesKishore Viswanathan, Kathleen M Frey, Eric W Scocchera, et al.The Journal of Biological Chemistry|December 16, 2011
Vitamin C deficiency activates the purine nucleotide cycle in zebrafishJay S Kirkwood, Katie M Lebold, Cristobal L Miranda, et al.BMC Medicine|August 6, 2011
Reduced perinatal mortality following enhanced training of birth attendants in the Democratic Republic of Congo: a time-dependent effectRichard Matendo, Cyril Engmann, John Ditekemena, et al.Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2014
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Mary A Vogler, Laura M Smeaton, Rodney L Wright, et al.American Journal of Surgery|August 20, 2024
Venous thromboembolic events associated with blood product administration in an era of whole blood useSteven G Schauer, Michael D April, Andrew D Fisher, et al.Journal of STEM Outreach|September 27, 2024
A Feasibility Study Describing the Successes and Challenges of Implementing a Virtual Community Health Worker Training Among High School Students Participating in a Summer STEM Enrichment ProgramArchana Bhavani Vasanth Kumar, Gia Grier McGinnis, Laundette Jones, et al.Oncotarget|November 16, 2017
PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesMilan S Geybels, Min Fang, Jonathan L Wright, et al.Cancer Treatment Reviews|April 3, 2004
Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidationGilda G Hillman, Nikoletta L Kallinteris, Xueqing Lu, et al.The American Surgeon|November 29, 2021
Whole Blood Versus Conventional Blood Component Massive Transfusion Protocol Therapy in Civilian Trauma PatientsJanet S Lee, Abid D Khan, Franklin L Wright, et al.Pageof 302